Amazon (NASDAQ: AMZN) is the No.2 best performing Initial Public Offering . . . turning a $1,000 investment into $2.1 million! Now Amazon founder Jeff Bezos is getting ready to launch his next IPO. Go here for urgent details...
The IPO party is starting right now . . . And this could be the biggest year since the dot-com boom. The average IPO is jumping 52% – handing early investors huge profits. Go here ASAP to discover Silicon Valley’s Pre-IPO Secret. One new...
The U.S. government is pulling out the stops. Today the Department of Health & Human Services agreed to buy millions of new Covid-19 vaccines. The initial order includes 100 million vaccines at a cost of $1.95 billion. The deal also allows the government to...
Three new and promising Covid-19 vaccines are emerging. Oxford University is producing a vaccine in partnership with AstraZeneca (NYSE: AZN). The drug is already in Phase III vaccine trials in Britain, Brazil and South Africa. According to a British medical journal, the vaccine trials...
Expect a Covid-19 vaccine soon . . . Researchers at Oxford University say they plan to have 30 million vaccines by September. They aim to have the Covid-19 vaccine ready before the second wave in the autumn. A Covid-19 vaccine is the ultimate solution,...
One Massachusetts biotech stock reports positive results from its vaccine trial. Moderna (NASDAQ: MRNA) is working with the National Institute of Allergy and Infectious Diseases (NIAID). The government agency has been testing the Covid-19 vaccine with 45 individuals. Participants received two injections spaced two...